<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d155" origId="L-Phenylalanine"><sentence id="DrugDDI.d155.s0" origId="s0" text="Non-selective monoamine oxidase (MAO) inhibitors - including phenelzine sulfate, tranylcypromine sulfate and pargyline HC1."><entity id="DrugDDI.d155.s0.e0" origId="s0.p0" charOffset="14-31" type="drug" text="monoamine oxidase"/><entity id="DrugDDI.d155.s0.e1" origId="s0.p6" charOffset="61-79" type="drug" text="phenelzine sulfate"/><entity id="DrugDDI.d155.s0.e2" origId="s0.p7" charOffset="81-104" type="drug" text="tranylcypromine sulfate"/><entity id="DrugDDI.d155.s0.e3" origId="s0.p9" charOffset="109-118" type="drug" text="pargyline"/><pair id="DrugDDI.d155.s0.p0" e1="DrugDDI.d155.s0.e0" e2="DrugDDI.d155.s0.e1" interaction="false"/><pair id="DrugDDI.d155.s0.p1" e1="DrugDDI.d155.s0.e0" e2="DrugDDI.d155.s0.e2" interaction="false"/><pair id="DrugDDI.d155.s0.p2" e1="DrugDDI.d155.s0.e0" e2="DrugDDI.d155.s0.e3" interaction="false"/><pair id="DrugDDI.d155.s0.p3" e1="DrugDDI.d155.s0.e1" e2="DrugDDI.d155.s0.e2" interaction="false"/><pair id="DrugDDI.d155.s0.p4" e1="DrugDDI.d155.s0.e1" e2="DrugDDI.d155.s0.e3" interaction="false"/><pair id="DrugDDI.d155.s0.p5" e1="DrugDDI.d155.s0.e2" e2="DrugDDI.d155.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d155.s1" origId="s1" text="Concomitant use of L-phenylalanine and non-selective MAO inhibitors may cause hypertension."><entity id="DrugDDI.d155.s1.e0" origId="s1.p11" charOffset="21-34" type="drug" text="phenylalanine"/><entity id="DrugDDI.d155.s1.e1" origId="s1.p13" charOffset="53-67" type="drug" text="MAO inhibitors"/><pair id="DrugDDI.d155.s1.p0" e1="DrugDDI.d155.s1.e0" e2="DrugDDI.d155.s1.e1" interaction="true"/></sentence><sentence id="DrugDDI.d155.s2" origId="s2" text="Selegiline - L-phenylalanine and the selective MAO inhibitor selegiline may have synergistic antidepressant activity if used concomitantly."><entity id="DrugDDI.d155.s2.e0" origId="s2.p17" charOffset="0-10" type="drug" text="Selegiline"/><entity id="DrugDDI.d155.s2.e1" origId="s2.p19" charOffset="47-60" type="drug" text="MAO inhibitor"/><entity id="DrugDDI.d155.s2.e2" origId="s2.p22" charOffset="93-107" type="drug" text="antidepressant"/><pair id="DrugDDI.d155.s2.p0" e1="DrugDDI.d155.s2.e0" e2="DrugDDI.d155.s2.e1" interaction="true"/><pair id="DrugDDI.d155.s2.p1" e1="DrugDDI.d155.s2.e0" e2="DrugDDI.d155.s2.e2" interaction="false"/><pair id="DrugDDI.d155.s2.p2" e1="DrugDDI.d155.s2.e1" e2="DrugDDI.d155.s2.e2" interaction="false"/></sentence><sentence id="DrugDDI.d155.s3" origId="s3" text="Neuroleptic Drugs - L-phenylalanine may potentiate the tardive dyskinesia side reactions of neuroleptic drugs if used concomitantly with them."><entity id="DrugDDI.d155.s3.e0" origId="s3.p26" charOffset="0-17" type="drug" text="Neuroleptic Drugs"/><entity id="DrugDDI.d155.s3.e1" origId="s3.p30" charOffset="92-109" type="drug" text="neuroleptic drugs"/><pair id="DrugDDI.d155.s3.p0" e1="DrugDDI.d155.s3.e0" e2="DrugDDI.d155.s3.e1" interaction="true"/></sentence></document>